Precision BioSciences, Inc.

NASDAQ:DTIL

Biotechnology

Healthcare
$6.91 +1.69%

+$0.11 today

Market cap
$193.04M
Beta
1.28
P/E (TTM)
-1.9
EPS (TTM)
-$3.47
52W Low $3.53High $8.82

Volume 0.27M

Average 0.31M

Balance Sheet

Inspect the capital base behind the business.

Assets

$154.42M

FY 2025 · Annual

+13.2% YoY

Liabilities

$62.17M

FY 2025 · Annual

-22.3% YoY

Equity

$92.25M

FY 2025 · Annual

+63.6% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents143.66M189.58M116.68M85.9M110.82M
Short-term Investments000413K4.76M
Net Receivables488K720K12.8M1.7M0
Inventory00000
Other Current Assets169K2.78M906K538K45K
Total Current Assets161.75M199.11M136.36M94.99M118.74M
Property, Plant & Equipment (Net)29.33M13.78M14.6M10.18M7.23M
Goodwill00000
Intangible Assets2.05M731K400K622K1.17M
Long-term Investments6.84M4.75M3.21M3.21M744K
Tax Assets00000
Other Non-current Assets11.52M19.81M5.22M27.39M26.54M
Total Non-current Assets49.74M39.06M23.42M41.4M35.68M
Total Assets211.5M238.17M159.78M136.39M154.42M
Account Payables1.14M653K2.97M1.31M296K
Short-term Debt0022.41M00
Tax Payables00000
Deferred Revenue21.24M46.19M12.04M2.96M0
Other Current Liabilities7.74M9.31M9.88M7.38M2.36M
Total Current Liabilities35.98M59.66M49.99M14.98M8.91M
Long-term Debt2.48M22.22M022.32M22.4M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)77.02M92.87M83.08M33.3M10M
Other Non-current Liabilities44K1.92M128K2.99M15.95M
Total Non-current Liabilities84.35M118.07M90.93M65.02M53.26M
Total Liabilities120.33M177.74M140.92M80M62.17M
Common Stock01K1K1K1K
Retained Earnings(316.68M)(428.31M)(489.63M)(482.46M)(528.19M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity91.17M60.43M18.86M56.39M92.25M
Total Debt9.11M24.96M31.27M30.05M28.81M
Net Debt(134.55M)(164.62M)(85.41M)(55.85M)(82.02M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$99.4M
Short-term Investments$1.8M
Receivables$4.0M
Other Current$3.5M
Total Current Assets$108.7M
PP&E (Net)$6.6M
Intangible Assets$1.1M
Long-term Investments$27.2M
Other Non-current$203.0K
Total Non-current Assets$35.2M
Total Assets$143.9M

Analysis

Selected assets total $143.9M for Latest. The largest visible component is Cash & Equivalents at $99.4M, about 69.1% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 12, 2026
8-KCurrent reportNov 9, 2026
424B5424B5 filingNov 6, 2026
8-KCurrent reportNov 6, 2026
FWPFWP filingNov 5, 2026

How much cash does DTIL have?

Precision BioSciences, Inc. (DTIL) reported $110.82M in cash and equivalents in fiscal 2025.

How much debt does DTIL carry?

Precision BioSciences, Inc. (DTIL) reported $28.81M of total debt, with net debt of -$82.02M.